Chetzemoka to Medicine@mander.xyz • 9 months agoTrial of semaglutide ends early based on successful demonstration of efficacy in sustaining kidney function in people with diabetes and kidney diseasewww.reuters.commessage-square0arrow-up143arrow-down10cross-posted to: medicine@mander.xyz
arrow-up143arrow-down1external-linkTrial of semaglutide ends early based on successful demonstration of efficacy in sustaining kidney function in people with diabetes and kidney diseasewww.reuters.comChetzemoka to Medicine@mander.xyz • 9 months agomessage-square0cross-posted to: medicine@mander.xyz